Sort
51,593 grants matching “hepatitis”
Genetic Regulation of Nonalcoholic Fatty Liver Disease
$537,831Marisa Wong Medina · University Of California, San Francisco · R01 · FY2024 · DK
Epidemiologic Study of Hepatocellular Carcinoma in the US
$537,816Herbert Yu · Yale University · R01 · FY2011 · CA
Alcohol-induced hepatotoxicity - implications of secretin/secretin receptor axis
$537,781Gianfranco D. Alpini · Indiana University Indianapolis · R01 · FY2022 · AA
Continuum of Care for Drug-Involved Offenders
$537,760Peter D. Friedmann · Rhode Island Hospital · U01 · FY2013 · DA
Role of evolving white matter damage in neurocognitive effects of HIV and HCV
$537,753Terry L Jernigan · University Of California, San Diego · R01 · FY2007 · MH
Metabolic Markers and Predictors of Childhood Obesity
$537,736Sonia Caprio · Yale University · R01 · FY2015 · HD
A 4D-tunable hydrogel for the study of the impact of the tumor microenvironment on the development of colorectal cancer
$537,714Nancy L Allbritton · University Of Washington · R01 · FY2025 · CA
STING-Dependent Pathways Restraining Severe Schistosome Immunopathology
$537,712Parisa Kalantari · Tufts University Boston · R01 · FY2020 · AI
HIV/STD Infection in an Urban High Risk Population
$537,693Larry Allen Nuttbrock · National Development And Research Institutes, Inc. · R01 · FY2008 · DA
Regulation of Drug Metabolizing Enzyme Ontogeny
$537,671D Gail McCarver · Medical College Of Wisconsin · R01 · FY2012 · GM
Molecular Mechanisms of Insulin Resistance Associated Loci
$537,659Thomas None Quertermous · Stanford University · R01 · FY2019 · DK
A single biosensors for the simultaneous molecular detection of HIV and Hepatitis B and C viruses at resource-limited settings
$537,619Karin Chumbimuni-Torres · University Of Central Florida · R15 · FY2025 · AI
The Development of TGR5 Antagonists for the Treatment of Cholangiopathies
$537,612Steven H Olson · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2019 · DK
Yale Drug use, Addiction and HIV Research Scholars (DAHRS)
$537,598Gail D'onofrio · Yale University · K12 · FY2018 · DA
Effect of structural interventions on substance use and HIV/HCV risk among rural PWUD
$537,587Jennifer R Havens · University Of Kentucky · R01 · FY2019 · DA
Identifying an immunoregulatory axis for FGF21 in alcohol consumption
$537,587Suraj J Patel · Ut Southwestern Medical Center · R01 · FY2025 · AA
Identifying an immunoregulatory axis for FGF21 in alcohol consumption
$537,587Suraj J Patel · Ut Southwestern Medical Center · R01 · FY2024 · AA
HBV Capsid Effectors
$537,558Raymond F. Schinazi · Emory University · R01 · FY2019 · AI
Small molecule allosteric inhibitors of PCSK9 processing to phenocopy cardioprotective genetic variants.
$537,538John S Chorba · University Of California, San Francisco · R61 · FY2023 · HL
Implementation of Seek, Test, Treat & Retain Strategies among People Who Inject Drugs in Malaysia
$537,496Marek C Chawarski · Yale University · R01 · FY2019 · DA
Community Wise: An innovative multi-level intervention to reduce alcohol and illegal drug use
$537,492Liliane Cambraia Windsor · University Of Illinois At Urbana-Champaign · U01 · FY2016 · MD
Spinal cord injury causes liver pathology and metabolic dysfunction
$537,485Dana M McTigue · Ohio State University · R01 · FY2022 · DK
Spinal cord injury causes liver pathology and metabolic dysfunction
$537,485Dana M McTigue · Ohio State University · R01 · FY2023 · DK
Spinal cord injury causes liver pathology and metabolic dysfunction
$537,485Dana M McTigue · Ohio State University · R01 · FY2025 · DK
Action Plans & Memory Consolidation: Reducing HIV Risk in Drug Users
$537,448Alan W Stacy · Claremont Graduate University · R01 · FY2014 · DA